NCT07166666

Study Comparing Atomizerd Midazolam & Fentanyl and Dexmedomidine for Procedural Sedation in Adult and Pediatric Patient (2 to 60 Years Old)

• Status: Not Yet Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 128 (estimated)
• Sponsor: Oman Medical Speciality Board · Other Government
• Sex: All
• Age: 2 Years – 60 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the depth of sedation, as well as onset, and recovery times, satisfaction of sedation , adverse events associated with Atomized Midazolam \& Fentanyl and Dexmedetomidine during procedural sedation in a diverse population spanning from 2 to 60 years old at these three prominent Omani healthcare facilities.

Conditions

• Sedation
• Analgesia Assessment

Interventions

Type	Name	Description
DEVICE	atomizer	use atomizer to provide the medication in procedure sedation
DRUG	rescue medication	will be used as rescue if the atomizer medication not fully sedated
DRUG	Midazolam	Intranasal administration for procedural sedation.
DRUG	fentanyl	Intranasal administration for procedural sedation.
DRUG	Dexmedetomidine	Intranasal administration for procedural sedation.
DRUG	Placabo	use atomizer to provide the placebo in procedure sedation

Timeline

• Start date: 2025-09-01
• Primary completion: 2026-09-30
• Completion: 2026-10-01
• First posted: 2025-09-10
• Last updated: 2025-09-10

Locations

1 site across 1 country: Oman